Physician profile
Athanasios D Diniotis
NPI 1538148093
$564.27
in general payments reported to CMS, 2019-2025
12 companies · $35.20 in 2025
The $35.20 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $25.36 · 2021: $58.54 · 2022: $39.06 · 2023: $189 · 2024: $13.35 · 2025: $35.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $166.67 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $95.84 | 2019 | |
| Abiomed | $48.55 | 2024-2025 | Impella |
| Innovation Technologies INC | $41.67 | 2021 | |
| Lemaitre Vascular, INC. | $39.06 | 2022 | |
| Covidien Lp | $38.41 | 2019 | |
| Becton, Dickinson and Company | $27.78 | 2019 | |
| Misonix INC | $25.36 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $25.06 | 2019 | |
| Avinger INC. | $22.41 | 2023 | Pantheris |
| Ethicon US, LLC | $16.87 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Athanasios Diniotis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.